AN Brown

553 total citations
20 papers, 492 citations indexed

About

AN Brown is a scholar working on Molecular Biology, Analytical Chemistry and Pharmacology. According to data from OpenAlex, AN Brown has authored 20 papers receiving a total of 492 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Molecular Biology, 7 papers in Analytical Chemistry and 6 papers in Pharmacology. Recurrent topics in AN Brown's work include Analytical Methods in Pharmaceuticals (7 papers), Pharmacogenetics and Drug Metabolism (5 papers) and Pharmaceutical Economics and Policy (5 papers). AN Brown is often cited by papers focused on Analytical Methods in Pharmaceuticals (7 papers), Pharmacogenetics and Drug Metabolism (5 papers) and Pharmaceutical Economics and Policy (5 papers). AN Brown collaborates with scholars based in United Kingdom, Switzerland and United States. AN Brown's co-authors include Robert J. Francis, Lata Kler, Hans R. Brunner, T. Fasanella D'amore, J. Nussberger, M Porchet, D. B. Brunner, B. Waeber, Bernard Waeber and Juerg Nussberger and has published in prestigious journals such as Antimicrobial Agents and Chemotherapy, International Journal of Radiation Oncology*Biology*Physics and British Journal of Clinical Pharmacology.

In The Last Decade

AN Brown

20 papers receiving 464 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
AN Brown United Kingdom 11 252 136 120 94 78 20 492
HJ Gomez United States 8 273 1.1× 142 1.0× 94 0.8× 79 0.8× 57 0.7× 9 494
T. Fasanella D'amore United States 10 223 0.9× 115 0.8× 118 1.0× 60 0.6× 41 0.5× 11 466
E H Ulm United States 10 269 1.1× 269 2.0× 104 0.9× 97 1.0× 69 0.9× 10 690
PA Meredith United Kingdom 14 315 1.3× 121 0.9× 115 1.0× 158 1.7× 22 0.3× 33 646
Lata Kler United Kingdom 11 206 0.8× 186 1.4× 207 1.7× 64 0.7× 46 0.6× 15 571
HL Elliott United Kingdom 17 381 1.5× 186 1.4× 147 1.2× 197 2.1× 33 0.4× 57 876
David A Willard United States 11 190 0.8× 176 1.3× 72 0.6× 33 0.4× 61 0.8× 14 569
R. Zacest Australia 12 224 0.9× 161 1.2× 80 0.7× 89 0.9× 18 0.2× 24 749
Sampat M. Singhvi Malaysia 8 191 0.8× 187 1.4× 46 0.4× 31 0.3× 49 0.6× 12 544
DA Willard United States 13 140 0.6× 72 0.5× 86 0.7× 74 0.8× 45 0.6× 18 592

Countries citing papers authored by AN Brown

Since Specialization
Citations

This map shows the geographic impact of AN Brown's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by AN Brown with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites AN Brown more than expected).

Fields of papers citing papers by AN Brown

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by AN Brown. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by AN Brown. The network helps show where AN Brown may publish in the future.

Co-authorship network of co-authors of AN Brown

This figure shows the co-authorship network connecting the top 25 collaborators of AN Brown. A scholar is included among the top collaborators of AN Brown based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with AN Brown. AN Brown is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Ihdayhid, Abdul Rahman, et al.. (2021). Coronary Perivascular Inflammation is Not Associated With Downstream Microcirculatory Dysfunction. Heart Lung and Circulation. 30. S184–S185. 1 indexed citations
2.
Brown, AN, et al.. (2016). Mantle cell lymphoma: primary oral presentation. Annals of The Royal College of Surgeons of England. 99(1). e13–e14. 3 indexed citations
3.
Dorr, Albert, et al.. (2000). The Comparative Pharmacokinetics and Safety of the Oral Neuraminidase Inhibitor Oseltamivir when Given in Multiple Doses to Healthy Japanese and Caucasian Subjects.. Rinsho yakuri/Japanese Journal of Clinical Pharmacology and Therapeutics. 31(2). 397–398. 1 indexed citations
4.
Kapp, Daniel S., et al.. (1993). Temperature differentials between treatment and pretreatment temperatures correlate with local control following radiotherapy and hyperthermia. International Journal of Radiation Oncology*Biology*Physics. 27(2). 331–344. 4 indexed citations
5.
Francis, Robert J., et al.. (1991). Initial and Steady State Pharmacokinetics of Cilazapril in Congestive Cardiac Failure. Journal of Pharmacy and Pharmacology. 43(6). 406–410. 3 indexed citations
6.
Williams, P.E., et al.. (1990). Pharmacokinetics of cilazapril during repeated oral dosing in healthy young volunteers. European Journal of Drug Metabolism and Pharmacokinetics. 15(1). 63–67. 3 indexed citations
7.
Moulin, Bruno, et al.. (1989). Pharmacokinetics of cilazapril in patients with renal failure.. British Journal of Clinical Pharmacology. 27(S2). 275S–282S. 21 indexed citations
8.
Brown, AN, et al.. (1989). The influence of food on the pharmacokinetics and ACE inhibition of cilazapril.. British Journal of Clinical Pharmacology. 27(S2). 205S–209S. 17 indexed citations
9.
Rosenthal, Éric, et al.. (1989). A pharmacokinetic study of cilazapril in patients with congestive heart failure.. British Journal of Clinical Pharmacology. 27(S2). 267S–273S. 12 indexed citations
10.
Brown, AN, et al.. (1989). The pharmacokinetics and bioavailability of cilazapril in normal man.. British Journal of Clinical Pharmacology. 27(S2). 181S–188S. 31 indexed citations
11.
Lin, Amy, et al.. (1989). The pharmacokinetics and dose proportionality of cilazapril.. British Journal of Clinical Pharmacology. 27(S2). 199S–204S. 13 indexed citations
12.
Brown, AN, et al.. (1989). A pharmacokinetic study of cilazapril in elderly and young volunteers.. British Journal of Clinical Pharmacology. 27(S2). 211S–215S. 18 indexed citations
13.
Francis, Robert J., AN Brown, Lata Kler, et al.. (1987). Pharmacokinetics of the Converting Enzyme Inhibitor Cilazapril in Normal Volunteers and the Relationship to Enzyme Inhibition: Development of a Mathematical Model. Journal of Cardiovascular Pharmacology. 9(1). 32–38. 89 indexed citations
14.
Nussberger, Juerg, T. Fasanella D'amore, M Porchet, et al.. (1987). Repeated Administration of the Converting Enzyme Inhibitor Cilazapril to Normal Volunteers. Journal of Cardiovascular Pharmacology. 9(1). 39–44. 97 indexed citations
15.
Nussberger, J., M Porchet, B. Waeber, et al.. (1987). Repeated Administration of the Converting Enzyme Inhibitor Cilazapril to Normal Volunteers. Journal of Cardiovascular Pharmacology. 9(1). 39–44. 8 indexed citations
16.
Francis, Robert J., AN Brown, Lata Kler, et al.. (1987). Pharmacokinetics of the Converting Enzyme Inhibitor Cilazapril in Normal Volunteers and the Relationship to Enzyme Inhibition: Development of a Mathematical Model. Journal of Cardiovascular Pharmacology. 9(1). 32–38. 2 indexed citations
17.
Nussberger, J., T. Fasanella D'amore, M Porchet, et al.. (1987). Repeated administration of the converting enzyme inhibitor cilazapril to normal volunteers.. PubMed. 9(1). 39–44. 120 indexed citations
18.
Brown, AN, et al.. (1985). Human pharmacokinetic and pharmacodynamic studies on Ro31‐1118, a new beta‐adrenoceptor antagonist.. British Journal of Clinical Pharmacology. 19(3). 319–327. 7 indexed citations
19.
Kroboth, Patricia D., et al.. (1982). Pharmacokinetics of single-dose erythromycin in normal and alcoholic liver disease subjects. Antimicrobial Agents and Chemotherapy. 21(1). 135–140. 24 indexed citations
20.
Allen, John G., et al.. (1976). Metabolism of Debrisoquine Sulphate in Rat, Dog and Man. Xenobiotica. 6(7). 405–409. 18 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by HJ Gomez Breakdown of academic impact, for papers by T. Fasanella D'amore Breakdown of academic impact, for papers by E H Ulm Breakdown of academic impact, for papers by PA Meredith Breakdown of academic impact, for papers by Lata Kler Breakdown of academic impact, for papers by HL Elliott Breakdown of academic impact, for papers by David A Willard Breakdown of academic impact, for papers by R. Zacest Breakdown of academic impact, for papers by Sampat M. Singhvi Breakdown of academic impact, for papers by DA Willard
Rankless by CCL
2026